These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22099423)

  • 1. Adiponectin and atherosclerosis risk factors in African hemodialysis patients: a population at low risk for atherosclerotic cardiovascular disease.
    Amira OC; Naicker S; Manga P; Sliwa K; Mia A; Raal F; Crowther NJ; Immelman RA; Olorunju S
    Hemodial Int; 2012 Jan; 16(1):59-68. PubMed ID: 22099423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma adiponectin levels for prediction of cardiovascular risk among hemodialysis patients.
    El-Shafey EM; Shalan M
    Ther Apher Dial; 2014 Apr; 18(2):185-92. PubMed ID: 24720410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adiponectin and cardiovascular outcomes among hemodialysis patients.
    Abdallah E; Waked E; Nabil M; El-Bendary O
    Kidney Blood Press Res; 2012; 35(4):247-53. PubMed ID: 22286012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between plasma adiponectin concentration and visceral fat accumulation in hemodialysis patients.
    Odamaki M; Furuya R; Kinumura Y; Ikegaya N; Kumagai H
    Nephron Clin Pract; 2006; 102(1):c8-13. PubMed ID: 16166803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adiponectin levels and arteriosclerotic risk factors in pediatric renal transplant recipients.
    Bakkaloglu SA; Soylemezoglu O; Buyan N; Oktar SO; Funahashi T; Pasaoglu H; Elhan AH; Peru H; Hasanoglu E
    Pediatr Transplant; 2006 Mar; 10(2):187-92. PubMed ID: 16573605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma adiponectin levels in chronic kidney disease patients: relation with molecular inflammatory profile and metabolic status.
    Norata GD; Baragetti I; Raselli S; Stucchi A; Garlaschelli K; Vettoretti S; Piloni G; Buccianti G; Catapano AL
    Nutr Metab Cardiovasc Dis; 2010 Jan; 20(1):56-63. PubMed ID: 19359150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atherosclerosis is associated with plasminogen activator inhibitor type-1 in chronic haemodialysis patients.
    Peng Y; Liu H; Liu F; Ouyang L; Cheng M; Gao L; Pan F; Liu Y; Chen X; Li J
    Nephrology (Carlton); 2008 Oct; 13(7):579-86. PubMed ID: 19161364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of metabolic syndrome and pulse wave velocity in hemodialysis patients: diagnosis of obesity by bioelectrical impedance analysis and a novel risk factor for atherosclerosis].
    Sasaki N; Takeda S; Saito T; Ando Y; Kusano E
    Nihon Jinzo Gakkai Shi; 2009; 51(4):476-83. PubMed ID: 19601557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma myeloperoxidase, NT-proBNP, and troponin-I in patients on CAPD compared with those on regular hemodialysis.
    Al-Hweish A; Sultan SS; Mogazi K; Elsammak MY
    Hemodial Int; 2010 Jul; 14(3):308-15. PubMed ID: 20597992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of high-molecular-weight adiponectin levels to visceral fat accumulation in hemodialysis patients.
    Tamei N; Ogawa T; Ishida H; Ando Y; Nitta K
    Intern Med; 2010; 49(4):299-305. PubMed ID: 20154435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body fat percentage as a risk factor for atherosclerosis but not for inflammation for hemodialysis patients: differences between genders.
    Sezer S; Karakan S; Saşak G; Tutal E; Ozdemir Acar FN
    J Ren Nutr; 2012 Sep; 22(5):490-8. PubMed ID: 22153383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular risk factors in hemodialysis and peritoneal dialysis patients.
    Helal I; Smaoui W; Hamida FB; Ouniss M; Aderrahim E; Hedri H; Elyounsi F; Maiz HB; Abdallah TB; Kheder A
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):59-62. PubMed ID: 20061694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between hypoadiponectinemia and cardiovascular risk factors in nonobese healthy adults.
    Im JA; Kim SH; Lee JW; Shim JY; Lee HR; Lee DC
    Metabolism; 2006 Nov; 55(11):1546-50. PubMed ID: 17046559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative DNA damage correlates with carotid artery atherosclerosis in hemodialysis patients.
    Ari E; Kaya Y; Demir H; Cebi A; Alp HH; Bakan E; Odabasi D; Keskin S
    Hemodial Int; 2011 Oct; 15(4):453-9. PubMed ID: 22111813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac troponin I and beta 2 microglobulin as risk factors for early-onset atherosclerosis in patients on haemodialysis.
    Zumrutdal A; Sezer S; Demircan S; Seydaoglu G; Ozdemir FN; Haberal M
    Nephrology (Carlton); 2005 Oct; 10(5):453-8. PubMed ID: 16221094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carotid atherosclerosis and endothelial cell adhesion molecules as predictors of long-term outcome in chronic hemodialysis patients.
    Papagianni A; Dovas S; Bantis C; Belechri AM; Kalovoulos M; Dimitriadis C; Efstratiadis G; Alexopoulos E; Memmos D
    Am J Nephrol; 2008; 28(2):265-74. PubMed ID: 17989499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there any relationship between serum levels of interleukin-10 and atherosclerosis in hemodialysis patients?
    Seyrek N; Karayaylali I; Balal M; Paydas S; Aikimbaev K; Cetiner S; Seydaoglu G
    Scand J Urol Nephrol; 2005; 39(5):405-9. PubMed ID: 16257843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atherosclerosis and vascular calcification are independent predictors of left ventricular hypertrophy in chronic haemodialysis patients.
    Yildiz A; Memisoglu E; Oflaz H; Yazici H; Pusuroglu H; Akkaya V; Erzengin F; Tepe S
    Nephrol Dial Transplant; 2005 Apr; 20(4):760-7. PubMed ID: 15716296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of high-molecular-weight to total adiponectin ratio with pulse wave velocity in hemodialysis patients.
    Kato A; Odamaki M; Ishida J; Hishida A
    Nephron Clin Pract; 2008; 109(1):c18-24. PubMed ID: 18493156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased high-density lipoprotein cholesterol is associated with inflammation and insulin resistance in non-diabetic haemodialysis patients.
    Peng YS; Chiu YL; Chen HY; Yang JY; Lai CF; Hsu SP; Pai MF
    Nephrology (Carlton); 2010 Oct; 15(7):692-9. PubMed ID: 21040164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.